The Great Lakes Node (GLN) is the organizational center for Clinical Trials Network (CTN) research in the Midwest, providing an infrastructure in which the National Institute on Drug Abuse (NIDA), academic centers, researchers, community-based service providers and patients can work together to develop, validate, refine, and disseminate new prevention and treatment options for substance use disorders (SUDs).
Who We Are
The National Drug Abuse Treatment Clinical Trials Network (CTN) consists of a national network of Nodes, a Clinical Coordinating Center, and a Data and Statistics Center. The CTN seeks to bridge the gap between research and practice by creating partnerships with an array of community partners to best understand and address the needs of individuals struggling with substance use.
The Great Lakes Node (GLN) is one of sixteen independent nodes. The Great Lakes Node consists of eight institutions, seven academic partners and five CTSA sites and provides the infrastructure needed to coordinate rigorous, multi-site clinical trials throughout the Midwest. Rush University Medical Center serves as the administrative core and operational center for the Great Lakes Node.
For more information about the Clinical Trials Network (CTN) click here.
Contact Us
1645 W. Jackson Blvd.,
Suite 302 Chicago, IL 60612
Phone: (312) 563-2113